Intraocular lymphoma is a rare neoplasm that occurs only in the eyes and/or central nervous system. Diagnosis of intraocular lymphoma is difficult because its clinical manifestations mimic chronic uveitis. Pathological examination of the vitreous is one of the main diagnostic tools for intraocular lymphoma, but this is challenging due to the sparse cellularity and specimen degeneration. Here, we reviewed 33 cell block preparations from vitreous perfusion fluid in order to examine the significance of cytopathological findings for differential diagnosis using vitreous samples. The cases comprised 12 intraocular lymphomas and 21 non-lymphomatous diseases. Cytologically, vitreous samples from non-lymphoma cases showed lower cellularity than the lymphoma cases. Whereas vitreous material from cases with infectious endophthalmitis showed prominent neutrophilic infiltration, material from sarcoidosis cases showed infiltration of small lymphoid cells, especially CD4-positive T cells. On the other hand, lymphoma cases showed higher cellularity, with large, irregular and atypical lymphoid cells, frequent necrotic cells in the background, and less pronounced neutrophil infiltration. Immunocytochemically, 11 of the 12 lymphoma cases were of the B-cell phenotype and the remaining case was of the T/NK-cell phenotype. In conclusion, careful cytopathological examination or immunocytochemistry of vitreous material facilitates appropriate diagnosis of intraocular lymphoma.
Intraocular lymphoma is a rare neoplasm manifesting as either primary intraocular lymphoma (PIOL) or secondary intraocular lymphoma. 1 In PIOL, only the eyes and/or central nervous system are affected, whereas in secondary intraocular lymphoma, a lymphoma located outside the eyes or central nervous system metastasizes to the eye. Approximately 42-92% of PIOL cases eventually lead to intracranial lymphoma, which means that the neoplasm is closely associated with primary central nervous system lymphoma (PCNSL). [1] [2] [3] [4] Intraocular lymphoma account for 1-2% of all extranodal lymphomas, and <1% of intraocular neoplasms. 1, 5 It is estimated that the incidence of intraocular lymphoma has been increasing in parallel with an increase in PCNSL. 6 Histologically, most intraocular lymphomas are classified as diffuse large B-cell lymphomas (DLBCLs). 7 Frequent symptoms of intraocular lymphoma at presentation include deterioration of visual acuity and blurred vision, which masquerade as chronic uveitis. Examination of the posterior segment reveals vitreous cells and haze or subretinal lesions, which are classically creamy lesions with orangeyellow infiltrates. Because biopsy from the retina is difficult and risky due to its anatomical and functional characteristics, vitrectomy is commonly undertaken for diagnosis of intraocular lymphoma. We previously reported the diagnostic efficacy of cell block preparation of vitreous samples compared to conventional smear cytology. 8 Still, diagnosis using vitreous material poses a challenge to pathologists owing to the sparse cellularity and possible degeneration of the samples.
In this study, we added further histological examination of various types of non-lymphoma cases to explore the significance of pathological diagnosis using vitreous materials. Furthermore, detailed immunocytochemical examination was performed to elucidate the immunophenotype of intraocular lymphoma.
MATERIALS AND METHODS

Patients
We retrospectively reviewed 37 samples from 33 patients obtained by vitrectomy at our hospital between June 2006 and March 2014. The medical records and pathology database were searched for the patients' age, gender, clinical diagnosis, history of lymphoma, presence of central nervous system (CNS) lesion, the levels of IL-6 and IL-10 in vitreous fluid, and immunoglobulin heavy chain (IgH) gene rearrangement in vitreous fluid. This study was approved by the Institutional Review Board on Ethical Issues of Hokkaido University Hospital, Sapporo, Japan.
The patients included 13 men and 20 women with a mean age of 64.6 years (range, 17-82 years). A final diagnosis of malignant lymphoma was made in 12 cases, and non-lymphoma in 21 cases, based on cytopathological review, clinical course, IL-10/IL-6 ratio in vitreous fluid and IgH gene rearrangement. Eleven of 12 malignant lymphoma cases were included in our previous study. 8 One T/NK-cell lymphoma (case 12) was previously reported. 9 Of the 12 lymphoma cases, 8 had a previous history or coexistence of extraocular lymphoma. Of these, 5 cases had a history or coexistence of CNS lymphoma, one case had a history of DLBCL of the right inguinal lymph node, one had a history of splenic DLBCL, and one had a coexisting bone marrow lesion (as detailed below). In 4 of the 5 cases of CNS lymphoma, biopsy had not been undertaken due to the patients' poor physical status. These latter 4 cases were diagnosed as CNS lymphoma on the basis of positron emission tomography (PET), magnetic resonance imaging (MRI) and vitreous fluid examination. The remaining case of CNS lymphoma was histologically proven CNS-DLBCL. The final clinicopathologic diagnoses of the non-lymphoma cases included infectious endophthalmitis in 6, uveitis of uncertain etiology in 6, epiretinal membrane in 2, sarcoidosis in 1, BehS cet's disease in 1, familial amyloidosis in 1, vitreous hemorrhage in 1, acute retinal necrosis in 1, vitreomacular traction syndrome in 1, and retinal detachment in 1.
Cytopathological examination
Cell block preparations were performed as follows. Vitreous perfusion fluid was centrifuged at 3000 rpm for 3 min and the supernatant was discarded. The dry pellet was fixed in 10% neutral buffered formalin overnight, and then the samples were processed for paraffin embedding and sectioning as usual.
For cytopathological examination, we examined cellularity, background appearance, cell types, and cell atypia. The extents of necrosis, neutrophils, histiocytes, small lymphocytes and atypical lymphocytes were scored as absent (À), mild (þ), moderate (þþ) or marked (þþþ).
In lymphoma cases or possible lymphoma cases, immunocytochemical staining was performed using antibodies against CD3 (clone LN10, RTU, Leica Biosystems, Nussloch, Germany), CD5 (Clone 4C7, Leica, RTU), CD20 (clone MJ1, RTU, Leica), CD10 (clone 56C6, RTU, Leica), CD56 (clone CD564, RTU, Leica), Bcl-2 (Clone bcl-2/100/D5, RTU, Leica), Bcl-6 (clone LN22, RTU, Leica), MUM-1 (clone EAU32, RTU, Leica) and Granzyme B (clone GrB-7, 1:50; MONOSAN, Uden, The Netherlands). For in situ hybridization, a Bond Readyto-Use ISH EBER Probe (Catalog No: PB0589probe; Leica) was used.
RESULTS
Cytopathological examination of non-lymphoma cases
Representative non-lymphoma cases are shown in Figs. 1 and 2. Non-lymphoma cases showed low cellularity and mixed cellular infiltration including neutrophils, histiocytes and small lymphocytes. In the case of retinal detachment, histiocytes with pigment deposition were frequent in a fibrinlike, eosinophilic background (Fig. 1a) . Neutrophils were sparse and lymphocytes were rarely seen (Fig. 1b) . The case of infectious endophthalmitis showed prominent neutrophils in a dirty, bluish background (Fig. 1c) . Histiocytes were also observed while lymphocytes were rare (Fig. 1d) . In the case of sarcoidosis, the cellularity was low, and the cells consisted of small lymphocytes without atypia and a few histiocytes in a clean background (Fig. 2a) . In the case of uveitis of uncertain etiology, the cellularity was also low and small lymphocytes without atypia were frequent in a clean background, similar to the H&E appearance of the sarcoidosis case (Fig. 2f) . The cytopathological features of the 21 non-lymphoma cases are summarized in Table 1 . In the non-lymphoma group, no case showed necrotic material in the background.
Of 21 cases, immunocytochemical staining was performed in 8 cases and was evaluable in 7 cases. In remaining 1 case, there was no evaluable cell in immunocytochemical staining. Most lymphocytes were positive for CD3 and negative for CD20 in all 7 cases (Fig. 2b ,c,g,h). In the case of sarcoidosis, those positive for CD4 outnumbered those positive for CD8, although the number of evaluable cell was very low (Fig. 2d,e) . On the other hand, both CD4-positive cells and CD8-positive cells were observed in equal numbers in the case of uveitis of uncertain etiology, (Fig. 2i,j) .
Cytopathological examination of lymphoma cases
A representative lymphoma case is shown in Fig. 3 . In the background, ghost-like necrotic cells were prominent (Fig.  3a) . Cellularity was relatively higher than in non-lymphoma cases. The majority of cells were atypical lymphocytes with hyperchromatic irregular nuclei, being larger than small lymphocytes (Fig. 3b) . Immunocytochemistry demonstrated positivity for CD20 in atypical cells and necrotic cells (Fig.  3d ). CD3 was negative in atypical lymphocytes but positive in small lymphocytes (Fig. 3c ). CD10 was negative atypical lymphocytes, but MUM-1 was positive (Fig. 3e,f) .
The cytopathological features of the 12 lymphoma cases are summarized in Table 2 . Ten of the 12 lymphoma cases (83.3%) showed atypical lymphocytes; however, we were unable to identify definitive atypical lymphocytes in 2 cases, due to sparse cellularity and cellular degeneration. On the other hand, necrotic material in the background was observed in 11 out of 12 lymphoma cases (91.7%), being the most characteristic feature. Eleven of the 12 cases showed a B-cell phenotype (91.7%), while the remaining case showed a T/NK-cell phenotype. One B-cell lymphoma case with a history of splenic DLBCL was negative for CD20, probably due to previous rituximab treatment; however, the alternative B-cell markers, CD79a and PAX5, were positive in lymphoma cells. In 9 of the 11 B-cell lymphoma cases, immunocytochemical staining for CD10, Bcl-6 and MUM-1 was performed, and all 9 cases were negative for CD10. The immunocytochemical phenotypes of Bcl-6 and MUM-1 were as follows: 4 cases were Bcl-6-positive/ MUM-1-positive, 3 cases were Bcl-6-negative/ MUM-1 positive, and 2 cases were Bcl-6-negative/ MUM-1-negative, all of which corresponded to the non-germinal center type. Furthermore, CD5 was positive in 1 of 5 cases, and Bcl-2 was positive in 4 of 4 cases. EBER-ISH was performed in only one B-cell lymphoma case; the result was positive in lymphoma cells although the staining was obscure due to non-specific staining of neutrophils.
The case of T/NK-cell lymphoma is shown in Fig. 4 . In the background, eosinophilic material was prominent, probably due to retinal detachment (Fig. 4a) . Necrotic material was not evident, and there were various cell types, including lymphoid cells, neutrophils, eosinophils and histiocytes. Immunocytochemical staining revealed that most lymphoid cells were positive for CD3 (Fig. 4b) and negative for CD20 (data not shown). We were unable to reach a diagnosis from this vitreous sample, but biopsy from the bone marrow showed large atypical lymphoid cells (Fig. 4f ), which were positive for CD3, CD56, Granzyme B and EBER-ISH ( Fig.  4g-j) . Clinicopathologically, this patient was diagnosed as 
having a mature NK/T-cell neoplasm. Retrospective immunocytochemical staining of vitreous material revealed a few CD56-positive, Granzyme B-positive and EBER-ISH-positive lymphocytes (Fig. 4c-e) . Together, the findings obtained from the vitreous sample were consistent with involvement of a mature NK/T-cell neoplasm.
Assessment of cytokines and IgH gene rearrangement using vitreous fluid
Measurement of IL-6 and IL-10 levels in vitreous fluid was performed in 18 cases. Among them, 8 cases showed an IL-10/IL-6 ratio higher than 1, while 10 cases showed a ratio lower than 1. Of the 11 lymphoma cases, 8 (72.7%) showed an IL-10/IL-6 ratio higher than 1. On the other hand, all nonlymphoma cases showed a ratio lower than 1. Information about IgH gene clonal rearrangement was available in 16 cases; 9 showed IgH gene rearrangement while 6 were negative for IgH gene rearrangement. The rearrangement analysis was unsuccessful in 1 case due to DNA degradation. Out of 11 B-cell-type lymphomas, 9 (81.8%) were positive for IgH gene rearrangement. All non-lymphoma cases and the T/NK-cell lymphoma case were negative for IgH rearrangement.
DISCUSSION
Although intraocular lymphoma is a rare intraocular neoplasm, its incidence is considered to be increasing along with that of PCNSL. Pathological diagnosis using samples of vitreous is important for reaching a definitive diagnosis of intraocular lymphoma, and is valuable in terms of its relatively low invasiveness. Also, CNS lymphoma with intraocular lesions is sometimes diagnosed based on vitreous material because brain biopsy is invasive. In this study, we reviewed 33 vitreous samples from 12 lymphoma cases and 21 non-lymphoma cases in order to examine the significance of pathological diagnosis using vitreous materials.
There have been several previous reports on cytologic diagnosis of intraocular lymphoma using vitreous material. 8, [10] [11] [12] However, cytologic appearance of non-lymphoma cases has not been fully elucidated. We investigated the characteristic appearance of intraocular lymphoma by reviewing not only lymphoma cases but also non-lymphoma cases, including retinal detachment, infectious endophthalmitis, sarcoidosis and uveitis of uncertain etiology. Our study revealed that necrotic material in the background, predominance of lymphocytes and cellular atypia were the key features for making a pathological diagnosis of intraocular lymphoma. In addition to cytomorphological examination, cell block preparation makes it possible to examine a variety of immunocytochemical stains retrospectively. In our research, immunocytochemical staining for CD10, Bcl-6 and MUM-1, as well as the routinely stained CD3 and CD20, was performed in 9 B-cell lymphoma cases. As reported previously, all 9 cases were negative for CD10. 7 Other immunophenotypes of intraocular lymphoma have not been fully elucidated, but it is known that most cases of PCNSL are positive for Bcl-6 and MUM-1, corresponding to the nongerminal center type of systemic DLBCL. 13, 14 In our study, all B-cell lymphoma cases corresponded to the nongerminal center type. Furthermore, CD5 was positive in 1 out of 5 cases, and Bcl-2 was positive in 4 out of 4 cases. EBER-ISH was performed in only one of 11 B-cell lymphoma cases, and the lymphoma cells were positive although the staining was obscure due to non-specific staining of neutrophils. These data may be of help when trying to understand the origin of intraocular lymphoma. Although most intraocular lymphoma have been considered DLBCL, further immunocytochemical examination including Ki-67 and MYC is needed in order to exclude other B-cell lymphoma and explore malignant potential. It's important to prepare enough unstained sections in advance to avoid sample loss. Additionally, we performed immunocytochemical staining in one case of sarcoidosis, and most lymphocytes were found to be positive for CD3, of which CD4-positive cells outnumbered CD8-positive cells. This result is consistent with a previous report that demonstrated the high diagnostic value of the CD4/CD8 ratio determined by flow cytometry of vitreous material in cases of ocular sarcoidosis. 15 It is suggested that immunocytochemical staining using cell block preparations could also be useful for diagnosis of non-lymphoma cases. Although we found cell block preparations to be diagnostically significant, pathological diagnosis may sometimes be challenging due to specimen paucity and cell degeneration. Accordingly, several adjunctive diagnostic tests are required to supplement pathologic diagnosis. Intraocular lymphoma is reported to exhibit a high IL-10/IL-6 ratio (>1) with approximately 81% sensitivity and 100% specificity. 16, 17 In our study, 8 out of 11 lymphoma cases (72.7%) exhibited a high IL-10/IL-6 ratio (>1) (data were not available in one case). One case of mature NK-cell neoplasm showed a low IL-10/IL-6 ratio, which indicates that different cytokine pathways are activated in T/NK-cell lymphoma. Furthermore, Bcell lymphoma cases with a low IL-10/IL-6 ratio may indicate the presence of different subtypes with different etiology in the DLBCL group. In addition to the IL-10/IL-6 ratio, clonality assay of B lymphocytes using IgH is useful for diagnosis of intraocular lymphoma. In this study, 9 out of 11 B-cell lymphomas (81.8%) showed IgH rearrangement. It is known that the IgH rearrangement test does not have 100% sensitivity. Furthermore, PCR-based IgH rearrangement assay may give a false-positive result. 18 Together, comprehensive assessment of all tests is required for accurate diagnosis of intraocular lymphoma. Our study included one T/NK-cell lymphoma that showed a distinctive appearance compared to B-cell lymphoma cases. In this case, various types of cells were observed, including lymphoid cells, neutrophils, eosinophils and histiocytes. Necrotic material in the background was not prominent, unlike the B-cell lymphoma cases. We were able to reach a diagnosis of T/NK-cell lymphoma by retrospective immunocytochemical staining after examination of bone marrow biopsy specimens. Because the IL-10/IL-6 ratio and IgH rearrangement are not reliable for diagnosis of T/NKcell lymphoma, cytopathological examination of vitreous material is essential. Pathologists should consider T/NK-cell lymphoma when encountering various types of cell, including atypical lymphoid cells, in vitreous samples, especially in cases with an aggressive clinical course.
In conclusion, we have reviewed 33 cell blocks of vitreous material from cases including both lymphoma and nonlymphomatous diseases. Our findings indicate that cell block preparations of vitreous material can be diagnostic for intraocular lymphoma when combined with careful cytomorphological and immunocytochemical examination, in addition to assessment of the IL-10/IL-6 ratio and IgH rearrangement.
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